British Columbia Takes on Big Pharma: Confronting the Opioid Crisis
British Columbia takes on Big Pharma in opioid crisis with a class-action lawsuit, aiming to hold pharmaceutical companies accountable for their role.
British Columbia takes on Big Pharma in opioid crisis with a class-action lawsuit, aiming to hold pharmaceutical companies accountable for their role.
British Columbia takes legal action against pharmaceutical companies for their alleged role in the opioid crisis, aiming to recover public healthcare costs.
The province of British Columbia is fighting a legal battle against pharmaceutical giants to hold them accountable for the ongoing opioid crisis.
The opioid crisis in Canada has led to increased crime rates and homelessness, with opioids becoming the drugs of choice for many individuals. Efforts to combat the crisis include legal action against pharmaceutical companies and the provision of Naloxone to minimize fatal overdoses.
The Canadian opioid crisis is a pressing issue with devastating consequences. British Columbia aims to certify a class action lawsuit against opioid manufacturers, while strategies like naloxone distribution and increased access to treatment are being implemented.
A new approach to homelessness in Ontario is being tested in response to the opioid crisis, offering permanent housing as the first step of intervention.
The Canadian opioid crisis persists in Hamilton, with rising homelessness, crime, and mortality rates. Efforts include naloxone distribution and a class action lawsuit.
The Canadian opioid crisis has devastating effects and efforts are being made to combat it, including a class-action lawsuit and the use of naloxone.
Canada is facing a severe opioid crisis, leading to increased homelessness and crime rates. Healthcare professionals are advocating for proactive measures.
Canadian opioid crisis: Updated treatment guidelines in British Columbia emphasize long-term care strategies and reducing criminal sanctions.